SMARTSTREAM
6.10.2020 10:02:07 CEST | Business Wire | Press release
SmartStream Technologies, the financial Transaction Lifecycle Management (TLM® ) solutions provider, today announces SmartStream Air version 2, the latest artificial intelligence (AI) technology to transform data quality and reconciliation processes that would usually be measured in weeks and months, to just seconds. In addition, with cloud-based technology accessed via a new user interface it manages large volumes of data, in any format, to achieve even higher match rates.
SmartStream Air version 2 has been launched to enable organisations with a unique solution to instantly compare all types of data sets, regardless of format and complexity. The latest version features inbuilt observational learning capabilities with a new AI technology called ‘Affinity’ – which automatically learns how records correlate to one another and can mimic and learn from actions made by a user. In just a few clicks, the AI establishes its own understanding of how records correlate and Affinity will assist the user to significantly reduce the time it takes for carrying out the matching of complex data sets. Ultra-fast matching results are delivered to the end-user with high-quality results.
This is the next-generation AI solution to be developed in the SmartStream Innovation Lab, and it delivers data quality and verification processes in an elastic cloud-based deployment model, using the latest technologies and digital friendly services. Customers are up and running straight-away and the solution can transform traditional data verification processes within seconds. Introducing Affinity as part of version two ensures any manually changed data matching activities get learnt and adopted for the algorithm’s future use.
SmartStream Air version 2 carries the PCI-DSS label, which is the most recognised data security standard, and has been certified at the highest level of security standards when hosting digital payments data. SmartStream’s solutions are also certified with SOC 1, SOC 2, SOC 3, attestation, and ISO 27001 and ISO 27002 standard. This ensures robust security controls across the whole organisation, including physical security, personnel security, fraud control mechanisms, IT & data security and data privacy.
Andreas Burner, Chief Innovations Officer, SmartStream, states: “We have 13 years of experience with cloud technologies and fully understand how these platforms need to behave. Also, this combined with our data scientists’ work and our powerful SmartStream Innovation Lab, we have the right level of experience to trustfully bring AI cloud technologies to the market, unlike any other vendor in the market today. With our new version of SmartStream Air and the encompassing AI technology, Affinity, both these capabilities know what needs to be done and the results are a lot faster than before. I’m very proud of our achievements, most notably with the user experience design, that enables non-IT staff to take multiple complex data sets and compare them within seconds. What's been really compelling is that you don't even need to understand the data, Affinity knows how to compare complex data sets and the results are achieved in seconds - it’s that simple”.
Victoria Harverson, Global Head of Business Development for SmartStream Air, states: “SmartStream Air is like nothing else, it transforms traditional operating models as it behaves like a consumer app and requires no training or configuration, and no IT projects are needed. We understand that when it comes to managing data and finding discrepancies quickly it’s of paramount importance that our customers have a solution for every scenario and don’t miss a thing. Controlling risks, delivering transformation projects and optimising data quality processes is going to be easier than ever with this introduction of our next generation AI application”.
About SmartStream
SmartStream is a recognised leader in financial transaction management solutions that enable firms to improve operational control, reduce costs, build new revenue streams, mitigate risk and comply accurately with the regulators.
By helping its customers through their transformative digital strategies, SmartStream provides a range of solutions for the transaction lifecycle with AI and machine learning technologies embedded - which can be deployed in the cloud or as managed services.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201006005113/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Murata Launches Ultra-Low Power AMR Sensors to Boost Battery Life in Healthcare and Wearables Devices27.4.2026 04:00:00 CEST | Press release
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has commenced mass production of its MRMS166R and MRMS168R anisotropic magnetoresistance (AMR) sensors for healthcare, wearable, and IoT devices. The MRMS166R is the first AMR sensor to combine an average current consumption of 20 nA with operation from a 1.2 V supply, enabling extended battery life in coin cell-powered systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260413296947/en/ [Murata Manufacturing Co., Ltd.] AMR sensor The devices are solid-state magnetic sensors used for switching applications. They detect the presence or absence of a magnetic field and generate an output signal that system logic uses to control functions such as transitions between active and sleep modes. This enables contactless switching without mechanical components, improving reliability, and supporting sealed, miniaturized designs. Automatic switching between active and
Sun Pharma signs Definitive Agreement to Acquire Organon27.4.2026 01:51:00 CEST | Press release
Organon stockholders to receive US$ 14.00 per share in cashThe deal values Organon at EV of US$ 11.75 billionCombined Business leverages complementary portfolios and global scale for sustained long‑term value creation Sun Pharmaceutical Industries Limited(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co. (NYSE: OGN) (“Organon”) today announced that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for US$ 14.00 per share in an all‑cash transaction with an enterprise valuation of US$ 11.75 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426881370/en/ Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, in 2021. Organon has a legacy of deep trust and strong brand equit
Andersen Global udvider sin tilstedeværelse i Afrika med lanceringen af medlemsfirma i Cameroun26.4.2026 20:56:00 CEST | Pressemeddelelse
Andersen Global træder ind på det camerounske marked, idet Phoenix Advisory bliver medlemsfirma og overgår til Andersen-brandet. Andersen in Cameroun er et specialiseret rådgivningsfirma, der leverer strategiske, erhvervsmæssige, finansielle og operationelle rådgivningsydelser til organisationer i forskellige vækstfaser. Firmaet er grundlagt af fagfolk med erfaring fra store internationale organisationer og kombinerer et stærkt lokalt og centralafrikansk funderet kendskab til forretningsmæssige, juridiske og skattemæssige regler med en skræddersyet tilgang, der har til formål at skabe konkrete og målbare resultater for klienterne. "Overgangen til Andersen-brandet afspejler vores engagement i at vokse sammen med vores kunder og imødekomme stadig mere komplekse behov," udtalte administrerende partner Albert Désiré Zang. "Vi tror på, at langsigtet succes skabes gennem tillid, kvalitet og vedvarende support. At blive et medlemsfirma styrker vores evne til at levere gennemtænkte, bæredygtig
PMCOrganometallix Announces Price Increase on All Products24.4.2026 22:55:00 CEST | Press release
Due to significant changes in market conditions, PMC Organometallix, Inc. announces that effective May 1, 2026, or as contracts permit, prices across all product lines globally will increase by 10-25%. This adjustment is driven by sustained cost pressures from key inputs including rising raw material costs and escalating freight and logistics expenses. While the company has been absorbing these increases, the current economic environment brought on by the geopolitical crisis of the Iran conflict requires this adjustment to continue providing the high-quality, consistent materials and supply reliability that customers expect. PMC Organometallix will implement these changes in a transparent, collaborative manner and values your partnership while navigating these economic challenges. Customers with questions or to discuss a specific situation should contact their account representative. About PMC Group PMC Group is a growth-oriented, diversified, global chemicals and plastics company deli
Frankfurt Higher Regional Court upholds BESREMi® arbitral award in favor of AOP Health24.4.2026 18:52:00 CEST | Press release
Today, the Higher Regional Court of Frankfurt upheld the February 20251 partial final ICC arbitral award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its dispute with PharmaEssentia Corp. (“PharmaEssentia”). The ruling confirms the award which found the Taiwanese company to be liable for certain damages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424005227/en/ Portrait Dr. Rudolf Widmann, Founder AOP Health Credit: AOP Health/Daniel Ospelt Dr. Rudolf Widmann, one of the two founders of AOP Health, explains: “We very much welcome the Frankfurt Higher Regional Court’s decision that confirms our position. In the interest of our patients, we are dedicated to maintaining stable and sustainable access to BESREMi® and to responsibly navigating future challenges.” The Product in Dispute The conflict centers around BESREMi® (ropeginterferon alfa-2b), a product launched in 2019 and developed by AOP Health into
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom